Filing Details

Accession Number:
0001093557-24-000012
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-17 18:49:59
Reporting Period:
2024-01-12
Accepted Time:
2024-01-17 18:49:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1093557 Dexcom Inc DXCM Surgical & Medical Instruments & Apparatus (3841) 330857544
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1286858 R Kevin Sayer 6340 Sequence Drive
San Diego CA 92121
President, Ceo And Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-01-12 72,709 $0.00 400,166 No 4 A Direct
Common Stock Disposition 2024-01-16 37,325 $123.63 362,841 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Represents performance stock units ("PSUs") granted to the reporting person on March 8, 2021 that vested on January 12, 2024.
  2. Included in this number are 115,682 unvested restricted stock units, 54,422 of which were granted on March 9, 2023 and shall vest through March 8, 2026, 43,336 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 17,924 of which were granted on March 8, 2021 and shall vest through March 8, 2024.
  3. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of PSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.